Online citations, reference lists, and bibliographies.
← Back to Search

Biodegradable Nanoparticles For Drug Delivery And Targeting

M. Hans, A. Lowman
Published 2002 · Materials Science

Cite This
Download PDF
Analyze on Scholarcy
Share
Throughout the world today, numerous researchers are exploring the potential use of polymeric nanoparticles as carriers for a wide range of drugs for therapeutic applications. Because of their versatility and wide range of properties, biodegradable polymeric nanoparticles are being used as novel drug delivery systems. In particular, this class of carrier holds tremendous promise in the areas of cancer therapy and controlled delivery of vaccines.
This paper references
10.1016/S0927-7765(99)00156-3
'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption.
Gref (2000)
10.1016/S0939-6411(97)00056-8
Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres
M. D. Blanco (1997)
10.1016/S0928-0987(98)00066-9
Stability and freeze-drying of cyclosporine loaded poly(D,L lactide-glycolide) carriers.
M. Chacón (1999)
10.1016/S0168-3659(00)00364-3
Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers.
S. Feng (2001)
10.1016/S0168-3659(01)00530-2
PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties.
K. Avgoustakis (2002)
10.1016/S0169-409X(00)00120-4
Mucoadhesive nanoparticulate systems for peptide drug delivery.
H. Takeuchi (2001)
10.1023/A:1012029517394
The Oral Absorption of Micro- and Nanoparticulates: Neither Exceptional Nor Unusual
A. Florence (2004)
10.1016/S0168-3659(00)00280-7
In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates.
H. Yoo (2000)
10.1016/S0169-409X(00)00119-8
Design of nanoparticles composed of graft copolymers for oral peptide delivery.
S. Sakuma (2001)
10.1016/S0378-5173(01)00760-8
Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A.
A. M. de Campos (2001)
10.1016/S0927-7757(00)00825-6
Preparation of PLGA nanoparticles containing estrogen by emulsification–diffusion method
Hye young Kwon (2001)
10.1016/S0168-3659(00)00339-4
Biodegradable polymeric nanoparticles as drug delivery devices.
K. Soppimath (2001)
10.1016/S0168-3659(98)00056-X
A poly(D,L-lactide-co-glycolide) microsphere depot system for delivery of haloperidol.
Y. Cheng (1998)
10.1016/S0142-9612(01)00030-8
Amoxicillin-loaded polyethylcyanoacrylate nanoparticles: influence of PEG coating on the particle size, drug release rate and phagocytic uptake.
G. Fontana (2001)
10.1016/S0168-3659(99)00063-2
Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting.
M. Peracchia (1999)
10.1016/S0168-3659(01)00519-3
Synthesis and characterization of poly(ethyl-2-cyanoacrylate) nanoparticles with a magnetic core.
J. Arias (2001)
10.1016/S0169-409X(00)00123-X
Polysaccharide colloidal particles as delivery systems for macromolecules.
K. Janes (2001)
10.1016/S0168-3659(99)00244-8
Nanoparticulate delivery system of a tyrphostin for the treatment of restenosis.
I. Fishbein (2000)
10.1016/S0169-409X(00)00121-6
Lymphatic targeting with nanoparticulate system.
Y. Nishioka (2001)
10.1016/S0378-5173(01)00676-7
Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles.
Z. Panagi (2001)
10.1016/S0378-5173(99)00153-2
Preparation of nanoparticles consisted of poly(L-lactide)-poly(ethylene glycol)-poly(L-lactide) and their evaluation in vitro.
J. Matsumoto (1999)
10.1016/S0142-9612(97)00246-9
Preparation, characterization and in vitro antimicrobial activity of ampicillin-loaded polyethylcyanoacrylate nanoparticles.
G. Fontana (1998)
10.1111/J.1768-322X.1987.TB00571.X
Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine
M. Aprahamian (1987)
10.1016/S0168-3659(98)00016-9
Arterial uptake of biodegradable nanoparticles for intravascular local drug delivery: results with an acute dog model.
C. Song (1998)
10.1016/S0168-3659(00)00367-9
Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation.
H. M. Redhead (2001)
10.1016/S0939-6411(98)00015-0
Preparation and characterization of nanoparticles containing an antihypertensive agent.
M. Leroueil-Le Verger (1998)
10.1016/S0169-409X(00)00122-8
Nanoparticulate systems for brain delivery of drugs.
J. Kreuter (2001)
10.1016/0168-3659(95)00164-6
Biodegradable nanoparticles — From sustained release formulations to improved site specific drug delivery
J. Leroux (1996)
10.1016/S0169-409X(00)00118-6
Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future.
R. Mueller (2001)
10.1016/S0142-9612(00)00286-6
Poly n-butyl cyanoacrylate nanoparticles: a mechanistic study of polymerisation and particle formation.
N. Behan (2001)
10.1016/S0939-6411(00)00125-9
Freeze-drying of polycaprolactone and poly(D,L-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs.
A. Saez (2000)
10.1016/S0168-3659(01)00218-8
PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats.
Y. Li (2001)
10.1016/S0169-409X(01)00184-3
Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas.
A. Florence (2001)
10.1016/S0378-5173(00)00632-3
Design of triptorelin loaded nanospheres for transdermal iontophoretic administration.
S. Nicoli (2001)
10.1016/S0168-3659(97)00241-1
Polymeric nanoparticles as delivery system for influenza virus glycoproteins.
D. Lemoine (1998)
10.1016/S0168-3659(96)01484-8
Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery
Cunxian Song (1997)
10.1016/S0378-5173(00)00364-1
Ex vivo and in situ PLGA microspheres uptake by pig ileal Peyer's patch segment.
A. Torché (2000)
10.1016/S0168-3659(01)00397-2
Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA.
C. Pérez (2001)
10.1016/S0169-409X(01)00171-5
Chitosan as a novel nasal delivery system for vaccines.
L. Illum (2001)
10.1002/(SICI)1097-4636(199811)42:2<331::AID-JBM19>3.0.CO;2-L
Regulation of smooth muscle cell proliferation using paclitaxel-loaded poly(ethylene oxide)-poly(lactide/glycolide) nanospheres.
H. Suh (1998)
10.1016/S0142-9612(02)00071-6
Synthesis and characterization of chitosan-poly(acrylic acid) nanoparticles.
Y. Hu (2002)
10.1016/S0168-3659(00)00201-7
Sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide)s facilitate the preparation of small negatively charged biodegradable nanospheres.
T. Jung (2000)
10.1016/S0168-3659(99)00247-3
Nanosphere based oral insulin delivery.
G. Carino (2000)
10.1016/S0168-3659(98)00116-3
PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug.
T. Govender (1999)
10.1016/S0168-3659(96)01475-7
Protein-loaded poly(dl-lactide-co-glycolide) microparticles for oral administration: formulation, structural and release characteristics
H. Rafati (1997)
10.1016/S0169-409X(00)00116-2
Nanoparticulate systems for the delivery of antisense oligonucleotides.
G. Lambert (2001)
10.1016/S0927-7765(99)00157-5
The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration.
Tobío (2000)
10.1016/S0378-5173(99)00187-8
Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method.
H. Murakami (1999)
10.1016/S0168-3659(01)00486-2
Design of biodegradable particles for protein delivery.
A. Vila (2002)



This paper is referenced by
10.1201/9781420007732.CH16
Nanotechnology in Drug Delivery for Malaria and Tuberculosis Treatment
H. Swai (2008)
10.5012/BKCS.2013.34.5.1333
Chitosan Nanoparticles as a New Delivery System for the Anti-HIV Drug Zidovudine
El Montassir Dahmane (2013)
10.1016/j.ejps.2013.08.036
Curcumin loaded poly(2-hydroxyethyl methacrylate) nanoparticles from gelled ionic liquid--in vitro cytotoxicity and anti-cancer activity in SKOV-3 cells.
Sathish Sundar Dhilip Kumar (2014)
10.2217/nnm.14.193
The impact of size on particulate vaccine adjuvants.
Ruchi R Shah (2014)
10.1007/s00396-015-3795-1
Self-assembly of Novel Poly(d,l-Lactide-co-Glycolide)-b-Poly(N-Vinylpyrrolidone) (PLGA-b-PNVP) Amphiphilic Diblock Copolymers
K. Ramesh (2015)
10.1016/J.CEJ.2012.04.010
Nanoparticle precipitation by Supercritical Assisted Injection in a Liquid Antisolvent
R. Campardelli (2012)
10.1007/s00396-016-4007-3
Biodegradable nanoparticles as nanomedicines: are drug-loading content and release mechanism dictated by particle density?
Caroline Santana Ribeiro (2017)
10.1093/mmy/myx155
Development, characterization, and in vitro‐in vivo evaluation of polymeric nanoparticles containing miconazole and farnesol for treatment of vulvovaginal candidiasis
Adelaide Fernandes Costa (2019)
10.1016/j.molimm.2019.09.015
Entrapment of HETS recombinant protein onto PLGA and alginate NPs improves the immunogenicity of the protein against E. coli O157:H7.
Emad Kordbacheh (2019)
DESIGN AND EVALUATION OF POLYLACTIC-CO-GLYCOLIC ACIDNANOPARTICLES CONTAINING SIMVASTATIN
Anilkumar Jalindar Shinde (2011)
10.1016/J.CARBPOL.2012.01.077
In situ enzymatic aided formation of xylan hydrogels and encapsulation of horse radish peroxidase for slow release
A. Chimphango (2012)
10.1016/j.msec.2015.11.019
Tamoxifen-loaded poly(L-lactide) nanoparticles: Development, characterization and in vitro evaluation of cytotoxicity.
C. Altmeyer (2016)
10.1007/s10096-015-2344-7
Potential chitosan-coated alginate nanoparticles for ocular delivery of daptomycin
J. Costa (2015)
10.1007/978-3-319-57696-1
Drug and Gene Delivery to the Central Nervous System for Neuroprotection
H. Sharma (2017)
10.1002/jbm.a.33220
Effect of thiol functionalization on the hemo-compatibility of PLGA nanoparticles.
Y. M. Thasneem (2011)
10.1016/j.mimet.2019.03.017
Lipid-polymer hybrid nanoparticles: Synthesis strategies and biomedical applications.
V. Dave (2019)
10.1002/DDR.20067
Magnetic nanoparticles for drug delivery
J. Dobson (2006)
10.1016/j.msec.2017.10.003
A review of recent progress in drug and protein encapsulation: Approaches, applications and challenges.
C. Ye (2018)
10.1002/wnan.1315
Nanomedical engineering: shaping future nanomedicines.
Dandan Luo (2015)
10.4028/www.scientific.net/KEM.254-256.887
Preparation of Nano-HAp as Vectors for Targeting Delivery System
You Duan (2003)
10.1016/J.POLYMER.2016.04.035
A facile chemoenzymatic synthesis of amphiphilic miktoarm star copolymers from a sugar core and their potential for anticancer drug delivery
M. Zhu (2016)
Estudo físico-químico comparativo de sistemas nanoestruturados contendo indometacina ou seu éster etílico e avaliação in vivo da atividade antiedematogênica
L. Cruz (2005)
10.1002/9781119242628.CH8
Biomedical Applications of Intelligent Nanomaterials
M. Fahmy (2017)
10.1088/2053-1591/ab63f5
Formulation and characterization of combretastatin A4 loaded PLGA nanoparticles
Abdel Naser Zaid (2020)
10.1007/978-4-431-55139-3_12
Functional Nanoparticles for Vaccine Delivery Systems
Takami Akagi (2014)
10.1016/j.jcis.2013.09.022
Construction of nanoparticles based on amphiphilic copolymers of poly(γ-glutamic acid co-L-lactide)-1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine as a potential drug delivery carrier.
Xiaoguang Liu (2014)
10.1039/C4TB01764A
Combination delivery of Adjudin and Doxorubicin via integrating drug conjugation and nanocarrier approaches for the treatment of drug-resistant cancer cells.
X. Li (2015)
10.1142/S179398441540005X
Poorly Water Soluble Drug Nanostructures via Surface Solvent Evaporation
Michael Graham (2015)
10.1016/B978-0-444-63930-1.00007-7
Curcumin, a Multitarget Phytochemical
Hélton José Wiggers (2017)
10.1007/S10973-009-0137-X
Calorimetric and spectrophotometric investigation of PLGA nanoparticles and their complex with DNA
M. Khvedelidze (2010)
10.3929/ETHZ-A-007139161
Synthesis, kinetics and functionalization of PLA and PLA based biomaterials
Yingchuan Yu (2011)
Benign Polymer Nanoparticles for Indomethacin and AcyclovirDelivery
Gina S. El-Feky (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar